RS55850B1 - Stabilni kristalni monohidrat epirubicin hidrohlorida i postupak za proizvodnju - Google Patents
Stabilni kristalni monohidrat epirubicin hidrohlorida i postupak za proizvodnjuInfo
- Publication number
- RS55850B1 RS55850B1 RS20170359A RSP20170359A RS55850B1 RS 55850 B1 RS55850 B1 RS 55850B1 RS 20170359 A RS20170359 A RS 20170359A RS P20170359 A RSP20170359 A RS P20170359A RS 55850 B1 RS55850 B1 RS 55850B1
- Authority
- RS
- Serbia
- Prior art keywords
- epirubicin hydrochloride
- solvent
- range
- crystalline
- monohydrate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13159392.3A EP2778171A1 (en) | 2013-03-15 | 2013-03-15 | Crystalline monohydrate of epirubicin hydrochloride |
| EP14159462.2A EP2778172B1 (en) | 2013-03-15 | 2014-03-13 | Stable crystalline monohydrate of epirubicin hydrochloride and method of production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS55850B1 true RS55850B1 (sr) | 2017-08-31 |
Family
ID=48013735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20170359A RS55850B1 (sr) | 2013-03-15 | 2014-03-13 | Stabilni kristalni monohidrat epirubicin hidrohlorida i postupak za proizvodnju |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20140271874A1 (enExample) |
| EP (2) | EP2778171A1 (enExample) |
| JP (1) | JP5964339B2 (enExample) |
| KR (1) | KR101751099B1 (enExample) |
| CN (1) | CN104045672B (enExample) |
| DK (1) | DK2778172T3 (enExample) |
| ES (1) | ES2623218T3 (enExample) |
| HU (1) | HUE034152T2 (enExample) |
| IN (1) | IN2014DE00737A (enExample) |
| PL (1) | PL2778172T3 (enExample) |
| PT (1) | PT2778172T (enExample) |
| RS (1) | RS55850B1 (enExample) |
| RU (2) | RU2630692C2 (enExample) |
| SI (1) | SI2778172T1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102155411B1 (ko) * | 2015-03-30 | 2020-09-11 | 메이지 세이카 파루마 가부시키가이샤 | 에피루비신 제조방법 및 그의 신규한 제조 중간체 |
| CN104861014B (zh) * | 2015-06-03 | 2017-09-29 | 道中道（菏泽）制药有限公司 | 一种盐酸表阿霉素结晶的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1155446B (it) | 1982-12-23 | 1987-01-28 | Erba Farmitalia | Procedimento per la purificazione di glucosidi antraciclinonici mediante adsobimento selettivo su resine |
| BRPI0408568A (pt) * | 2003-03-21 | 2006-03-21 | Dsm Ip Assets Bv | triidrato de amoxicilina |
| US20090099346A1 (en) * | 2003-07-02 | 2009-04-16 | Victor Matvienko | Thermally stable crystalline epirubicin hydrochloride |
| EP1638509B1 (en) * | 2003-07-02 | 2015-12-30 | Solux Corporation | Thermally stable crystalline epirubicin hydrochloride and method of making the same |
| GB0902009D0 (en) * | 2009-02-09 | 2009-03-11 | Innospec Ltd | Improvements in fuels |
| ES2351494B1 (es) * | 2009-06-30 | 2011-11-28 | Consejo Superior De Investigaciones Cientificas (Csic) (85,7%) | Material organo-inorganico microporoso cristalino basado en cationes alcalinoterreos, procedimiento de preparacion y usos |
| KR101125460B1 (ko) | 2010-03-24 | 2012-03-28 | 동아제약주식회사 | 에피루비신 염산염의 신규한 결정형 |
| CN102120750B (zh) * | 2011-01-30 | 2013-04-03 | 山东新时代药业有限公司 | 一种盐酸表柔比星的纯化方法 |
| DE102011103751A1 (de) * | 2011-05-31 | 2012-12-06 | Heraeus Precious Metals Gmbh & Co. Kg | Kristallisierung von Epirubicinhydrochlorid |
-
2013
- 2013-03-15 EP EP13159392.3A patent/EP2778171A1/en not_active Withdrawn
-
2014
- 2014-03-13 RU RU2014109682A patent/RU2630692C2/ru active
- 2014-03-13 SI SI201430193A patent/SI2778172T1/sl unknown
- 2014-03-13 CN CN201410092353.9A patent/CN104045672B/zh active Active
- 2014-03-13 HU HUE14159462A patent/HUE034152T2/en unknown
- 2014-03-13 PL PL14159462T patent/PL2778172T3/pl unknown
- 2014-03-13 JP JP2014049587A patent/JP5964339B2/ja active Active
- 2014-03-13 EP EP14159462.2A patent/EP2778172B1/en active Active
- 2014-03-13 IN IN737DE2014 patent/IN2014DE00737A/en unknown
- 2014-03-13 US US14/208,133 patent/US20140271874A1/en not_active Abandoned
- 2014-03-13 RS RS20170359A patent/RS55850B1/sr unknown
- 2014-03-13 KR KR1020140029344A patent/KR101751099B1/ko active Active
- 2014-03-13 ES ES14159462.2T patent/ES2623218T3/es active Active
- 2014-03-13 PT PT141594622T patent/PT2778172T/pt unknown
- 2014-03-13 DK DK14159462.2T patent/DK2778172T3/en active
-
2017
- 2017-05-23 RU RU2017117890A patent/RU2700683C2/ru active
-
2019
- 2019-07-24 US US16/520,767 patent/US20190382432A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR101751099B1 (ko) | 2017-06-26 |
| RU2700683C2 (ru) | 2019-09-19 |
| RU2630692C2 (ru) | 2017-09-12 |
| CN104045672B (zh) | 2017-09-15 |
| HK1199264A1 (en) | 2015-06-26 |
| RU2017117890A (ru) | 2018-11-26 |
| US20190382432A1 (en) | 2019-12-19 |
| IN2014DE00737A (enExample) | 2015-06-19 |
| EP2778172A1 (en) | 2014-09-17 |
| KR20140113441A (ko) | 2014-09-24 |
| SI2778172T1 (sl) | 2017-07-31 |
| HUE034152T2 (en) | 2018-01-29 |
| JP5964339B2 (ja) | 2016-08-03 |
| PL2778172T3 (pl) | 2017-08-31 |
| CN104045672A (zh) | 2014-09-17 |
| RU2014109682A (ru) | 2015-09-20 |
| DK2778172T3 (en) | 2017-04-10 |
| EP2778172B1 (en) | 2017-02-01 |
| JP2014181235A (ja) | 2014-09-29 |
| EP2778171A1 (en) | 2014-09-17 |
| PT2778172T (pt) | 2017-05-03 |
| RU2017117890A3 (enExample) | 2018-11-26 |
| US20140271874A1 (en) | 2014-09-18 |
| ES2623218T3 (es) | 2017-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20020016862A (ko) | 마크롤라이드 | |
| CN114149476B (zh) | 一种核糖核苷类似物的多晶型物、其制备方法及应用 | |
| RS66905B1 (sr) | Kristalni oblici ozanimoda i ozanimod hidrohlorida i procesi za njihovu pripremu | |
| CN118434732A (zh) | Tolebrutinib的晶型及其制备方法和用途 | |
| US9206215B2 (en) | Hydrous crystalline 2-O-α-D-glucosyl-L-ascorbic acid, particulate composition comprising the same, their preparation and uses | |
| US20190382432A1 (en) | Stable crystalline monohydrate of epirubicin hydrochloride and method of production | |
| WO2013018779A1 (ja) | α－グルコシルヘスペリジンの結晶とその用途 | |
| US9169257B2 (en) | Crystal forms of adefovir dipivoxil and processes for preparing the same | |
| EP2342212A1 (en) | Thermally stable crystalline epirubicin hydrochloride | |
| CN107793458A (zh) | 一种单磷酸阿糖腺苷的制备方法 | |
| CN114105969A (zh) | Btrx-335140的晶型及其制备方法 | |
| HK1199264B (en) | Stable crystalline monohydrate of epirubicin hydrochloride and method of production | |
| CN108570045A (zh) | 氢溴酸山莨菪碱的晶型、其制备方法、药物组合物 | |
| CN115894440B (zh) | 奥布替尼化合物的晶型及其制备方法 | |
| CN115991729A (zh) | 20(s)-原人参二醇晶型a、晶型b及其制备方法 | |
| WO2010084502A1 (en) | A crystalline form of orlistat and a process thereof | |
| Poornima et al. | Solid-state screening and evaluation of pioglitazone hydrochloride | |
| Shiraki | Physical characterization of TRK-720 hydrate, the very late antigen-4 (VLA-4) inhibitor, as a solid form for inhalation: preparation of the hydrate by solvent exchange among its solvates and mechanistical considerations | |
| CN113801182B (zh) | 一种阿扎胞苷晶型d | |
| EP2507250A1 (en) | Solid state forms of fosamprenavir calcium salt and process for preparation thereof | |
| CN107868117B (zh) | 司坦唑醇糖精盐及其制备方法和应用 | |
| CN107663217B (zh) | 替诺福韦艾拉酚胺结晶化合物及其制备方法 | |
| CN121399108A (zh) | Baxdrostat的晶型及其制备方法和用途 | |
| TR2025010500T2 (tr) | (15a,16a,17ß)-ESTRA-1,3,5(10)-TRIEN-3,15,16,17-TETROL (ESTETROL) MONOHİDRATININ HAZIRLANMASINA YÖNELİK BİR PROSES | |
| Florence et al. | Crystallization in Final Stages of Purification |